PDCD6P1: A Potential Drug Target Or Biomarker for Various Diseases

Target Name: PDCD6P1

NCBI ID: G728613

PDCD6P1

Other Name(s): PDCD6 pseudogene 1

PDCD6P1: A Potential Drug Target Or Biomarker for Various Diseases

PDCD6P1 (PDCD6 pseudogene 1) is a gene that has been identified as a potential drug target or biomarker for the treatment of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The PDCD6P1 gene is located on chromosome 11 and encodes a protein known as PDCD6, which plays a role in the immune response and cell signaling.

PDCD6 is a key regulator of the T-cell response, which is a critical part of the immune system that helps the body fight off infections and diseases. T-cells are a type of white blood cell that are responsible for recognizing and responding to foreign substances in the body, such as viruses and cancer cells. PDCD6 helps regulate the movement of T-cells into the body, as well as their activation and proliferation.

PDCD6P1 has also been shown to play a role in the development and progression of various diseases. For example, studies have shown that PDCD6P1 is expressed in human tissues and that it is involved in the development of cancer, including breast, ovarian, and prostate cancer. Additionally, PDCD6P1 has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases.

PDCD6P1 has also been identified as a potential biomarker for these diseases, as levels of PDCD6P1 have been shown to be elevated in the brains of individuals with these conditions. This suggests that PDCD6P1 may be a useful diagnostic or predictive marker for these diseases.

In addition to its potential as a drug target or biomarker, PDCD6P1 is also of interest to researchers because of its location on chromosome 11. This is because many diseases are caused by mutations in genes that are located on the same chromosome, known as genetic mutations. By studying the genetic changes that occur in PDCD6P1, researchers may be able to identify new targets for drug development or new ways to diagnose and treat diseases.

Overall, PDCD6P1 is a promising gene for drug development and research into the treatment of various diseases. Further studies are needed to fully understand its role and potential as a drug target or biomarker.

Protein Name: PDCD6 Pseudogene 1

The "PDCD6P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PDCD6P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets